Stock Scorecard
Stock Summary for Hologic Inc (HOLX) - $75.71 as of 4/26/2024 3:19:49 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HOLX
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HOLX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HOLX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for HOLX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for HOLX
Financial Details for HOLX
Company Overview |
|
---|---|
Ticker | HOLX |
Company Name | Hologic Inc |
Country | USA |
Description | Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging. |
Sector Name | LIFE SCIENCES |
Industry Name | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/2/2024 |
Stock Price History |
|
Last Day Price | 75.71 |
Last Day Price Updated | 4/26/2024 3:19:49 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 1,665,743 |
52-Week High | 87.88 |
52-Week Low | 64.02 |
Last Price to 52 Week Low | 18.26% |
Valuation Measures |
|
Trailing PE | 36.36 |
Industry PE | 36.36 |
Sector PE | 56.64 |
5-Year Average PE | 26.65 |
Free Cash Flow Ratio | 9.20 |
Industry Free Cash Flow Ratio | 9.20 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 3.89 |
Total Cash Per Share | 8.23 |
Book Value Per Share Most Recent Quarter | 19.84 |
Price to Book Ratio | 3.90 |
Industry Price to Book Ratio | 3.90 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 4.57 |
Industry Price to Sales Ratio Twelve Trailing Months | 4.57 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 234,732,000 |
Market Capitalization | 17,771,559,720 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.29% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 37.30% |
Annual Earnings Growth | -64.98% |
Reported EPS 12 Trailing Months | 2.11 |
Reported EPS Past Year | 0.98 |
Reported EPS Prior Year | 3.95 |
Net Income Twelve Trailing Months | 515,100,000 |
Net Income Past Year | 456,000,000 |
Net Income Prior Year | 1,302,000,000 |
Quarterly Revenue Growth YOY | -5.70% |
5-Year Revenue Growth | 4.61% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 1,932,100,000 |
Total Cash Past Year | 2,722,500,000 |
Total Cash Prior Year | 2,339,500,000 |
Net Cash Position Most Recent Quarter | -628,000,000 |
Net Cash Position Past Year | -95,700,000 |
Long Term Debt Past Year | 2,818,200,000 |
Long Term Debt Prior Year | 2,823,400,000 |
Total Debt Most Recent Quarter | 2,560,100,000 |
Equity to Debt Ratio Past Year | 0.64 |
Equity to Debt Ratio Most Recent Quarter | 0.65 |
Total Stockholder Equity Past Year | 5,016,900,000 |
Total Stockholder Equity Prior Year | 4,876,200,000 |
Total Stockholder Equity Most Recent Quarter | 4,653,800,000 |
Options |
|
Put/Call Ratio | 6.82 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.07 |
MACD Signal | 0.23 |
20-Day Bollinger Lower Band | 70.15 |
20-Day Bollinger Middle Band | 74.46 |
20-Day Bollinger Upper Band | 78.77 |
Beta | 1.02 |
RSI | 51.80 |
50-Day SMA | 74.59 |
200-Day SMA | 72.93 |
System |
|
Modified | 4/27/2024 2:33:19 AM EST |